Position history for BlackRock, Inc.'s holdings in LIGAND PHARMACEUTICALS INC
BlackRock, Inc. holds 3M shares of LGND (LIGAND PHARMACEUTICALS INC), worth $591.3M as of 2026-Q1. The position was increased (+0.7% shares). LGND represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$591.3M
Current Shares
3M
Total Value Change
+$275.7M
Total Shares Change
+15,839
Other major holders of LGND: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 3M |
+0.7% |
| $591.3M |
| 0.0% |
| $204.24 |
32 |
| 2025-Q4 | Increased | 2.9M | +1.9% | $555.9M | 0.0% | $190.20 | 32 |
| 2025-Q3 | Decreased | 2.9M | -1.0% | $511M | 0.0% | $173.13 | 0 |
| 2025-Q2 | Decreased | 2.9M | -0.2% | $331.2M | 0.0% | $114.15 | 0 |
| 2025-Q1 | Decreased | 2.9M | -0.9% | $307M | 0.0% | $107.62 | 0 |
| 2024-Q4 | New | 2.9M | - | $315.7M | 0.0% | $105.76 | 43 |